PL2197287T3 - Zastosowanie szczepu bifidobacterium do wytwarzania kompozycji przeznaczonej do zapobiegania i/lub leczenia objawów typu alergicznego - Google Patents

Zastosowanie szczepu bifidobacterium do wytwarzania kompozycji przeznaczonej do zapobiegania i/lub leczenia objawów typu alergicznego

Info

Publication number
PL2197287T3
PL2197287T3 PL08858623T PL08858623T PL2197287T3 PL 2197287 T3 PL2197287 T3 PL 2197287T3 PL 08858623 T PL08858623 T PL 08858623T PL 08858623 T PL08858623 T PL 08858623T PL 2197287 T3 PL2197287 T3 PL 2197287T3
Authority
PL
Poland
Prior art keywords
prevention
manufacture
treatment
composition intended
allergic symptoms
Prior art date
Application number
PL08858623T
Other languages
English (en)
Other versions
PL2197287T5 (pl
Inventor
Cécile AUBERT-JACQUIN
Francis Lecroix
Emmanuel Perrin
Valérie PETAY
Original Assignee
Compagnie Gervais Danone
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39580478&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2197287(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Compagnie Gervais Danone filed Critical Compagnie Gervais Danone
Publication of PL2197287T3 publication Critical patent/PL2197287T3/pl
Publication of PL2197287T5 publication Critical patent/PL2197287T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C21/00—Whey; Whey preparations
    • A23C21/02—Whey; Whey preparations containing, or treated with, microorganisms or enzymes
    • A23C21/026—Whey; Whey preparations containing, or treated with, microorganisms or enzymes containing, or treated only with, lactic acid producing bacteria, bifidobacteria or propionic acid bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/519—Breve

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Pediatric Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL08858623.5T 2007-10-03 2008-10-02 Zastosowanie szczepu bifidobacterium do wytwarzania kompozycji przeznaczonej do zapobiegania i/lub leczenia objawów typu alergicznego PL2197287T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0706925A FR2921795B1 (fr) 2007-10-03 2007-10-03 Utilisation d'une souche de bifidobacterium,pour la preparation d'une composition destinee a la prevention et/ou au traitement de manifestations de type allergique
PCT/FR2008/001372 WO2009074754A1 (fr) 2007-10-03 2008-10-02 Utilisation d'une souche de bifidobacterium, pour la preparation d'une composition destinee a la prevention et/ou au traitement de manifestations de type allergique
EP08858623.5A EP2197287B2 (fr) 2007-10-03 2008-10-02 Utilisation d'une souche de bifidobacterium, pour la preparation d'une composition destinee a la prevention et/ou au traitement de manifestations de type allergique

Publications (2)

Publication Number Publication Date
PL2197287T3 true PL2197287T3 (pl) 2020-11-16
PL2197287T5 PL2197287T5 (pl) 2025-05-05

Family

ID=39580478

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08858623.5T PL2197287T5 (pl) 2007-10-03 2008-10-02 Zastosowanie szczepu bifidobacterium do wytwarzania kompozycji przeznaczonej do zapobiegania i/lub leczenia objawów typu alergicznego

Country Status (11)

Country Link
US (1) US9707258B2 (pl)
EP (1) EP2197287B2 (pl)
CN (2) CN101848643A (pl)
AR (1) AR068726A1 (pl)
BR (1) BRPI0817905A2 (pl)
ES (1) ES2782375T5 (pl)
FR (1) FR2921795B1 (pl)
MY (1) MY168203A (pl)
PL (1) PL2197287T5 (pl)
RU (1) RU2522282C2 (pl)
WO (1) WO2009074754A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011121379A1 (en) * 2010-03-30 2011-10-06 Assistance Publique - Hopitaux De Paris Use of bifidobacteria for preventing allergy in breastfed infants
WO2011148219A1 (en) * 2010-05-28 2011-12-01 Compagnie Gervais Danone Probiotic strains for use in improving the enteric nervous system
EP2449891A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Drinking yoghurt preparations containing non-replicating probiotic micro-organisms
AU2011328041A1 (en) * 2010-11-11 2013-05-23 Nestec S.A. Spoonable yogurt preparations containing non-replicating probiotic micro-organisms
EP3406267A1 (en) 2011-03-25 2018-11-28 Children's Medical Center Corporation Lin28-mediated control of let-7 biogenesis
EP2986157B1 (en) 2013-04-08 2020-02-12 N.V. Nutricia Fermented nutritional composition with thiol protease inhibitor
BR112016009357B1 (pt) 2013-11-04 2021-09-14 N.V. Nutricia Usos de um ingrediente fermentado e oligossacarídeos não digeríveis na fabricação de uma fórmula para fórmula para recém-nascido ou de continuação para uso na redução da incidência de cólicas em um recém-nascido
CA3018768C (en) 2016-03-31 2024-03-26 Gojo Industries, Inc. Antimicrobial peptide stimulating sanitizing composition
US10874700B2 (en) 2016-03-31 2020-12-29 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
WO2017173240A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
JP2020500860A (ja) 2016-11-23 2020-01-16 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティック／プレバイオティックな有効成分を含む消毒薬組成物
WO2019212329A1 (en) * 2018-04-30 2019-11-07 N.V. Nutricia Formula with specific beta-lactoglobulin peptides
US20220386637A1 (en) * 2019-11-11 2022-12-08 Kabushiki Kaisha Yakult Honsha Method for producing fermented milk containing oligosaccharides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
FR2795917B1 (fr) 1999-07-06 2001-08-31 Gervais Danone Sa Procede de preparation d'un produit lacte immunostimulant et ses applications
NZ537242A (en) * 2002-06-21 2008-10-31 Newcastle Innovation Ltd Probiotic propionibacterium jensenii 702
KR100507417B1 (ko) * 2003-01-27 2005-08-10 (주) 피엘바이오 알레르기 질환 예방 및 치료 기능을 가진 유산균과 이를 함유한 항알레르기 제품
US20050175630A1 (en) * 2003-12-23 2005-08-11 Eyal Raz Immunogenic compositions and methods of use thereof

Also Published As

Publication number Publication date
ES2782375T5 (en) 2025-06-02
PL2197287T5 (pl) 2025-05-05
WO2009074754A1 (fr) 2009-06-18
FR2921795A1 (fr) 2009-04-10
MY168203A (en) 2018-10-15
US20100221226A1 (en) 2010-09-02
BRPI0817905A2 (pt) 2014-10-07
EP2197287B2 (fr) 2025-03-12
RU2010117248A (ru) 2011-11-10
AR068726A1 (es) 2009-12-02
RU2522282C2 (ru) 2014-07-10
US9707258B2 (en) 2017-07-18
CN101848643A (zh) 2010-09-29
EP2197287A1 (fr) 2010-06-23
EP2197287B1 (fr) 2020-01-08
FR2921795B1 (fr) 2011-04-29
ES2782375T3 (es) 2020-09-14
CN105724570A (zh) 2016-07-06

Similar Documents

Publication Publication Date Title
PL2197287T3 (pl) Zastosowanie szczepu bifidobacterium do wytwarzania kompozycji przeznaczonej do zapobiegania i/lub leczenia objawów typu alergicznego
CY2023002I1 (el) Συνθεσεις και χρησεις για αντιμετωπιση πολλαπλης σκληρυνσης
HUS2100009I1 (hu) Halauxifen-metil és piroxszulam kombinációja
IT1396074B1 (it) Composizione ad attivita' termogenetica potenziata e suo impiego nella prevenzione e trattamento dell'obesita'
HUE061548T2 (hu) Komplementtel összefüggõ rendellenességek kezelésére szolgáló eljárások és készítmények
ZA200908711B (en) Methods and compositions for treating allergic diseases
ES2525801T8 (es) Composiciones y métodos para la prevención y el tratamiento de enfermedades autoinmunes
EP2249854A4 (en) IMPROVED TREATMENT AND PROPHYLAXIS
EP2512313A4 (en) PERSONAL CARE COMPOSITION FOR IMPROVING VELVETY AND SOFTNESS AND ARTICLES USING THE SAME
AP2965A (en) Therapeutic compositions and the use thereof
IL232956A0 (en) Treatment and prevention of Edosis
EP2007385A4 (en) CARDIOVASCULAR COMPOSITION AND ITS USE FOR THE TREATMENT OF MORBUS ALZHEIMER
AP2490A (en) Therapeutic compositions and the use thereof
FI20070745L (fi) Sähkökäytön annon rajoittaminen sekä hissin suojaus
SI2185581T1 (sl) Postopki in sestavki, uporabni v zdravljenju mukozitisa
IL196465A0 (en) Compositions and methods for the treatment of mucositis
HRP20160902T1 (hr) Pripravci i postupci uporabe forbolskih estera
EP2097513A4 (en) MANUFACTURE AND USE OF CELLS SYNTHETIZED FIBS
IL210997A0 (en) Compositions for the treatment of mrsa and uses thereof
EP2079526A4 (en) COMPOSITIONS AND ITS USES IN THE TREATMENT OF WOUNDS
EP2066174A4 (en) COMPOSITIONS CONTAINING ALPHA-1-ANTITRYPSIN AND METHODS OF USE
GB0718446D0 (en) Compositions and methods for the treatment of infection
EP2282648A4 (en) PREBIOTIC COMPOSITIONS AND MANUFACTURING AND USE METHOD THEREFOR
BRPI0819105A2 (pt) composição para o tratamento e prevenção de edema de pálpebra
PT2185581E (pt) Processos e composições úteis no tratamento de mucosite